Clinical trial

Adaptive Nutrition and Exercise Weight Loss (A-NEW) Study

NCT04499950

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-02-08

PhasePHASE2

Study timeline

Study start (actual)2021-02-08Date precision: day

Registry last updated2025-03-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Overweight or Obesityunresolved

Interventions

ContraveDRUG · verified · RxNorm: Contrave

Behavioral Weight LossBEHAVIORAL

Sponsors & collaborators

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkinslead sponsor

American Institute for Cancer Researchcollaborator

Breast Cancer Research Foundationcollaborator

Hopkins-WellSpan Cancer Research Fundcollaborator

Mapped research locations

BaltimoreMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04499950 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.